Skip to content

Insider · CIK 0001434978

Jack H Dean

director

Files at ACXP (Acurx Pharmaceuticals, Inc.). First filing Jan 8, 2025, latest Jan 8, 2025.

Jack H Dean files SEC Form 4 as director at ACXP (Acurx Pharmaceuticals, Inc.). Since Jan 8, 2025, Jack H Dean has reported 1 open-market buy worth $10,000 and 0 open-market sells worth $0, the latest filed on Jan 8, 2025.

A track record needs three past buys with six months of prices behind them; Jack H Dean has 0, so none is measured yet.

The newest scored trade: bought $10,000 of ACXP on Jan 6, 2025, filed Jan 8, 2025, scored 40 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$10,000 bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ACXP: Acurx Pharmaceuticals, Inc.

ACXPOct 9, 2026 · close 1.27

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
ACXPbuy 6
Acurx Pharmaceuticals, Inc.
$10,000
9,852 shares
+83%-

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 20, 2026ACXP
Acurx Pharmaceuticals, Inc.
AGrant or award
Stock Optionderivative
+2,150$0.00$02,150Apr 22, 2026
Jan 6, 2025ACXP
Acurx Pharmaceuticals, Inc.
POpen-market purchase
Common Stock
+9,852$1.02$10,00021,776Jan 8, 2025
Jan 6, 2025ACXP
Acurx Pharmaceuticals, Inc.
POpen-market purchase
Warrants for Common Stockderivative
+9,852$0.00$09,852Jan 8, 2025

Questions about Jack H Dean

Answered from the filings on this page, as of the latest one.

Is Jack H Dean buying or selling?

Not in the last 12 months. Jack H Dean's latest open-market trade on SEC Form 4 was bought $10,000 of ACXP on Jan 6, 2025.

How did Jack H Dean's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jack H Dean has 0.

Where does Jack H Dean file Form 4?

Jack H Dean has filed Form 4 at ACXP (Acurx Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.